.After checking out at period 1 data, Nuvation Bio has made a decision to stop work with its own sin...
.Zevra Rehabs' unusual disease medication appears to be on the pathway to authorization this fall af...
.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) genetics therapy failing has blown a $230 million ...
.After more than two decades of deal with neurodegenerative ailments, Swiss biotech a/c Immune syste...
.GSK has actually broken up a stage 2 human papillomavirus (HPV) injection coming from its pipe afte...
.Operating system Therapies are going to note on the NYSE American stock swap today by means of a $6...
.ALX Oncology's phase 2 stomach cancer response rate has diminished. After finding its CD47 blocker ...
.One More of Ionis Pharmaceuticals' key midphase readouts has disappointed desires, prompting the bi...
.While Biogen's pharma peers are looking for late-stage resources along with little threat, CEO Chri...
.Instil Bio has actually been actually a biotech trying to find a pipe after it junked its own lead ...